gemcitabine has been researched along with indole-3-carbinol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, C; Haefele, A; Hammons, G; Lyn-Cook, BD; Mohammed, SI; Wang, H; Word, B | 1 |
| Lyn-Cook, BD; Wang, H; Word, BR | 1 |
| Hwang, JH; Kim, HR; Lee, SH; Paik, WH; Park, JK; Song, BJ | 1 |
3 other study(ies) available for gemcitabine and indole-3-carbinol
| Article | Year |
|---|---|
Gender differences in gemcitabine (Gemzar) efficacy in cancer cells: effect of indole-3-carbinol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Deoxycytidine; DNA Modification Methylases; Drug Synergism; Enzyme Inhibitors; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Genes, p16; Humans; Indoles; Male; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Sex Factors | 2010 |
Enhanced efficacy of gemcitabine by indole-3-carbinol in pancreatic cell lines: the role of human equilibrative nucleoside transporter 1.
Topics: Cell Death; Cell Line, Tumor; Deoxycytidine; Drug Synergism; Equilibrative Nucleoside Transporter 1; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Indoles; Pancreatic Neoplasms; RNA, Messenger; Treatment Outcome | 2011 |
Chemosensitivity induced by down-regulation of microRNA-21 in gemcitabine-resistant pancreatic cancer cells by indole-3-carbinol.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Cell Cycle; Cell Proliferation; Deoxycytidine; Down-Regulation; Drug Resistance, Neoplasm; Gemcitabine; Humans; Indoles; MicroRNAs; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; RNA, Messenger; Tumor Cells, Cultured | 2013 |